IBIO, INC. Pay versus Performance
The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.
- 2026-06-30: PEO Dr. Martin B. Brenner; PEO total compensation $2.14M; PEO compensation actually paid $2.31M; Other NEO average total compensation $1.02M.
- 2025-06-30: PEO total compensation $1.51M; PEO compensation actually paid $621.72K; Other NEO average total compensation $741.49K.
- 2024-06-30: PEO total compensation $1.27M; PEO compensation actually paid $1.18M; Other NEO average total compensation $761.87K.
- 2025-06-30: PEO Dr. Martin B. Brenner; PEO total compensation $1.51M; PEO compensation actually paid $621.72K; Other NEO average total compensation $741.49K.
| Fiscal year end | PEO | PEO total compensation | PEO compensation actually paid | Other NEO average total compensation | Other NEO average compensation actually paid | Total shareholder return | Peer group total shareholder return | Net income | Company-selected measure | Proxy filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Dr. Martin B. Brenner | $2.14M | $2.31M | $1.02M | $1.09M | $14.18 | -$32.84M | cumulative return on a fixed investment of $100 in the Common Stock of iBio, Inc. $100.00 | 2026-09-04 | |
| 2025-06-30 | $1.51M | $621.72K | $741.49K | $432.77K | $6.25 | -$18.38M | 2026-09-04 | |||
| 2024-06-30 | $1.27M | $1.18M | $761.87K | $742.38K | $17.30 | -$24.91M | 2026-09-04 | |||
| 2025-06-30 | Dr. Martin B. Brenner | $1.51M | $621.72K | $741.49K | $432.77K | $0.58 | -$18.38M | cumulative return on a fixed investment of $100 in the Common Stock of iBio, Inc. $100.00 | 2025-10-06 | |
| 2024-06-30 | $1.27M | $1.18M | $761.87K | $742.38K | $1.60 | -$24.91M | 2025-10-06 | |||
| 2023-06-30 | $630.74K | $336.31K | $9.24 | -$65.01M | 2025-10-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |